A team from Roswell Park Cancer Institute has discovered a unique population of normal stem cells that may enable prostate cancer relapse. These findings may point the way toward strategies for treating or preventing prostate cancer recurrence.
Article Correctness Is Author's Responsibility: Roswell Park Research Suggests New Strategy for Unleashing Cancer-Fighting Power of p53 Gene
In a new study in the journal Nature Communications, a research team from Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate the tumor suppressor p53, opening up new avenues for cancer research and treatm…
Article Correctness Is Author's Responsibility: Roswell Park Hematology Experts Sharing New Research in ASH 2017 Podium Presentations
Dr. Eunice Wang was invited to discuss results of a phase II clinical trial of crenolanib for adults with AML at the ASH 2017 annual meeting, and Dr. Kara Kelly, senior author of an oral abstract on outcomes disparities among children and adolescents w…
Article Correctness Is Author's Responsibility: Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects
The first consensus recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC).
Article Correctness Is Author's Responsibility: The Oncogene FOXQ1 Promotes Some Tumor Types, Suppresses Another
In a new study published in Cell Reports, scientists report an unexpected finding — that the oncogene FOXQ1 suppresses the growth of melanoma cells.
Article Correctness Is Author's Responsibility: Team Develops Fluorescent Sensors That May Pave Way for New Cancer Therapies
New research led by a team from Roswell Park Cancer Institute and published in the journal Nature Methods reports the development of the first tool for detecting changes in GTP levels in living cells.
Article Correctness Is Author's Responsibility: Beta Blockers May Hold Key to Unleashing Potential of Checkpoint Inhibitors, Roswell Park Team Shows
In new research published in the journal Cancer Research, a team from Roswell Park has shown that “beta blocker” drugs appear to be an effective means of reducing beta-2 receptor signaling and, in the process, may improve the efficacy of checkpoint i…
